Arkolith/Insider Trading/XTNT/Form 4

Schallenberger Mark A.

Chief Operating OfficerXtant Medical Holdings, Inc. (XTNT) · full profile →Form 4 · filed Nov 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2025Grant(A)292K—$0671K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2025Grant(A)585K—$0585K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001960742-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML